172 related articles for article (PubMed ID: 35186166)
1. Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration in Ovarian Cancer.
Nie L; Zhang C; Song H; Zhao Q; Cheng L; Zhang P; Yang X
Dis Markers; 2022; 2022():3554100. PubMed ID: 35186166
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinoma.
Ni PZ; He JZ; Wu ZY; Ji X; Chen LQ; Xu XE; Liao LD; Wu JY; Li EM; Xu LY
Oncol Rep; 2017 Dec; 38(6):3608-3618. PubMed ID: 29039594
[TBL] [Abstract][Full Text] [Related]
3. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
4. Stathmin 1 promotes the progression of liver cancer through interacting with YAP1.
Liu YP; Pan LL; Kong CC
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7335-7344. PubMed ID: 32706072
[TBL] [Abstract][Full Text] [Related]
5. miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
Chakravarthi BVSK; Chandrashekar DS; Agarwal S; Balasubramanya SAH; Pathi SS; Goswami MT; Jing X; Wang R; Mehra R; Asangani IA; Chinnaiyan AM; Manne U; Sonpavde G; Netto GJ; Gordetsky J; Varambally S
Mol Cancer Res; 2018 Jul; 16(7):1125-1137. PubMed ID: 29025958
[TBL] [Abstract][Full Text] [Related]
6. High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer.
Suzuki K; Watanabe A; Araki K; Yokobori T; Harimoto N; Gantumur D; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Kubo N; Gombodorj N; Nishiyama M; Hosouchi Y; Kuwano H; Shirabe K
Anticancer Res; 2018 Feb; 38(2):939-944. PubMed ID: 29374725
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer.
Hemdan T; Lindén M; Lind SB; Namuduri AV; Sjöstedt E; de Ståhl TD; Asplund A; Malmström PU; Segersten U
Br J Cancer; 2014 Sep; 111(6):1180-7. PubMed ID: 25072257
[TBL] [Abstract][Full Text] [Related]
8. miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1.
Wang X; Peng L; Gong X; Zhang X; Sun R; Du J
Cell Physiol Biochem; 2018; 50(6):2249-2259. PubMed ID: 30423576
[TBL] [Abstract][Full Text] [Related]
9. High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma.
Bao P; Yokobori T; Altan B; Iijima M; Azuma Y; Onozato R; Yajima T; Watanabe A; Mogi A; Shimizu K; Nagashima T; Ohtaki Y; Obayashi K; Nakazawa S; Bai T; Kawabata-Iwakawa R; Asao T; Kaira K; Nishiyama M; Kuwano H
Ann Surg Oncol; 2017 Dec; 24(13):4017-4024. PubMed ID: 28933054
[TBL] [Abstract][Full Text] [Related]
10. Elevated STMN1 promotes tumor growth and invasion in endometrial carcinoma.
He X; Liao Y; Lu W; Xu G; Tong H; Ke J; Wan X
Tumour Biol; 2016 Jul; 37(7):9951-8. PubMed ID: 26815505
[TBL] [Abstract][Full Text] [Related]
11. Stathmin 1 is a potential novel oncogene in melanoma.
Chen J; Abi-Daoud M; Wang A; Yang X; Zhang X; Feilotter HE; Tron VA
Oncogene; 2013 Mar; 32(10):1330-7. PubMed ID: 22665054
[TBL] [Abstract][Full Text] [Related]
12. Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer.
Kang W; Tong JH; Chan AW; Lung RW; Chau SL; Wong QW; Wong N; Yu J; Cheng AS; To KF
PLoS One; 2012; 7(3):e33919. PubMed ID: 22470493
[TBL] [Abstract][Full Text] [Related]
13. Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours.
Dos Santos Passaia B; Lima K; Kremer JL; da Conceição BB; de Paula Mariani BM; da Silva JCL; Zerbini MCN; Fragoso MCBV; Machado-Neto JA; Lotfi CFP
Invest New Drugs; 2020 Jun; 38(3):899-908. PubMed ID: 31441020
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer.
Nie W; Xu MD; Gan L; Huang H; Xiu Q; Li B
Lab Invest; 2015 Jan; 95(1):56-64. PubMed ID: 25384122
[TBL] [Abstract][Full Text] [Related]
15. MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1.
Zhu L; Chen Y; Nie K; Xiao Y; Yu H
Cancer Biomark; 2018; 23(2):301-309. PubMed ID: 30198871
[TBL] [Abstract][Full Text] [Related]
16. High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients.
Bai T; Yokobori T; Altan B; Ide M; Mochiki E; Yanai M; Kimura A; Kogure N; Yanoma T; Suzuki M; Bao P; Kaira K; Asao T; Katayama A; Handa T; Gombodorj N; Nishiyama M; Oyama T; Ogata K; Kuwano H
Br J Cancer; 2017 Apr; 116(9):1177-1185. PubMed ID: 28334732
[TBL] [Abstract][Full Text] [Related]
17. Stathmin1 overexpression in hypopharyngeal squamous cell carcinoma: A new promoter in FaDu cell proliferation and migration.
Chen Y; Zhang Q; Ding C; Zhang X; Qiu X; Zhang Z
Int J Oncol; 2017 Jan; 50(1):31-40. PubMed ID: 27878293
[TBL] [Abstract][Full Text] [Related]
18. Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.
Obayashi S; Horiguchi J; Higuchi T; Katayama A; Handa T; Altan B; Bai T; Bao P; Bao H; Yokobori T; Nishiyama M; Oyama T; Kuwano H
Int J Oncol; 2017 Sep; 51(3):781-790. PubMed ID: 28766688
[TBL] [Abstract][Full Text] [Related]
19. Reduced STMN1 expression induced by RNA interference inhibits the bioactivity of pancreatic cancer cell line Panc-1.
Li J; Hu GH; Kong FJ; Wu KM; He B; Song K; Sun WJ
Neoplasma; 2014; 61(2):144-52. PubMed ID: 24299310
[TBL] [Abstract][Full Text] [Related]
20. CircRNA ZNF609 promotes angiogenesis in nasopharyngeal carcinoma by regulating miR-145/STMN1 axis.
Wang J; Lin Y; Jiang DH; Yang X; He XG
Kaohsiung J Med Sci; 2021 Aug; 37(8):686-698. PubMed ID: 33943007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
